Success Metrics

Clinical Success Rate
80.4%

Based on 41 completed trials

Completion Rate
80%(41/51)
Active Trials
4(5%)
Results Posted
49%(20 trials)
Terminated
10(14%)

Phase Distribution

Ph phase_4
23
32%
Ph phase_1
13
18%
Ph phase_2
15
21%
Ph phase_3
10
14%
Ph not_applicable
9
12%

Phase Distribution

13

Early Stage

15

Mid Stage

33

Late Stage

Phase Distribution70 total trials
Phase 1Safety & dosage
13(18.6%)
Phase 2Efficacy & side effects
15(21.4%)
Phase 3Large-scale testing
10(14.3%)
Phase 4Post-market surveillance
23(32.9%)
N/ANon-phased studies
9(12.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.4%

41 of 53 finished

Non-Completion Rate

22.6%

12 ended early

Currently Active

4

trials recruiting

Total Trials

73

all time

Status Distribution
Active(4)
Completed(41)
Terminated(12)
Other(16)

Detailed Status

Completed41
unknown16
Terminated10
Recruiting3
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
73
Active
4
Success Rate
80.4%
Most Advanced
Phase 4

Trials by Phase

Phase 113 (18.6%)
Phase 215 (21.4%)
Phase 310 (14.3%)
Phase 423 (32.9%)
N/A9 (12.9%)

Trials by Status

unknown1622%
terminated1014%
recruiting34%
withdrawn23%
active_not_recruiting11%
completed4156%

Recent Activity

Clinical Trials (73)

Showing 20 of 73 trialsScroll for more
NCT05061368Phase 2

Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD

Recruiting
NCT04565925Phase 2

Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries

Recruiting
NCT04344678Not Applicable

The Phosphodiesterase 5 Inhibitor Sildenafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Withdrawn
NCT06178523Phase 4

Cost-effective Treatment of Unexplained Infertility

Completed
NCT04898114Phase 1

Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn

Recruiting
NCT01817751Phase 2

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Completed
NCT04169191Phase 1

Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia

Active Not Recruiting
NCT00871065Phase 2

Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm

Withdrawn
NCT05951413Phase 2

The Effect of Sildenafil Citrate on Frozen Embryo Transfer Cycles

Unknown
NCT05846906Phase 2

Effect of Oral Sildenafil Citrate on Improvement of Endometrial Thickness

Completed
NCT03686813Phase 2

Sildenafil for Swimming-Induced Pulmonary Edema (SIPE) Prevention

Completed
NCT02990078

Non-invasive Measurement of Cerebrovascular Reactivity After Traumatic Brain Injury

Terminated
NCT05558176Phase 4

Intrapartum Sildenafil Citrate to Prevent Non Reassuring Foetal Status Among Parturients Delivering at Term

Unknown
NCT03417492Phase 1

Cerebrovascular Reactivity in American Football Players

Terminated
NCT02060487Phase 4

Effects of Oral Sildenafil on Mortality in Adults With PAH

Terminated
NCT04283435Phase 1

Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium

Unknown
NCT03356353Phase 3

Sildenafil for the Prevention of Right Heart Failure Following LVAD Implantation

Unknown
NCT00159913Phase 3

A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.

Completed
NCT00468650Phase 4

A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction.

Completed
NCT01247805Phase 1

A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions

Completed

Drug Details

Intervention Type
DRUG
Total Trials
73